In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
about
Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malariaPyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trialThe activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasitesSafety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials.Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India.Pyronaridine: a new 'old' drug on the verge of entering the antimalarial armamentarium.Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine.Plasmodium vivax treatments: what are we looking for?Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax.The global pipeline of new medicines for the control and elimination of malariaThe Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridineField-based flow cytometry for ex vivo characterization of Plasmodium vivax and P. falciparum antimalarial sensitivityKnow your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.The Biology of Plasmodium vivax.Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya.The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium falciparum.In Vitro Sensitivity of Pyronaridine in Thai Isolates of Plasmodium falciparum.Diagnosis and Treatment of Plasmodium vivax Malaria.
P2860
Q24198103-71771B47-B0E4-4DCE-AAD0-9D71F311FBECQ28476754-80F597A4-EB67-4F25-A4E6-05137DCE5D46Q28480979-AD5439BC-21D2-4406-AD6B-DB57D5B70CBBQ30592761-E1C9EA5F-7E03-4922-B0D4-66D08FD5C8B6Q33612286-0986444A-F32F-4EA1-8CD0-BB08D72D0C68Q33876781-BB7910FC-F7F6-4F2D-8F7C-4569C77398A0Q35068138-CE42EF0D-607C-40C0-941F-C4CB511F6181Q35760893-C3B61C14-1F11-4DA9-808D-192413354C4EQ35834198-C834CEA3-F6B9-48A7-8F03-7032E9C9E2C2Q36232661-56FBEC3A-F7EB-4E22-83B4-32FE793B0853Q36320249-0DC3726A-C8E9-4C66-A637-C2E12EE6FFC8Q36560464-EF189DE8-9C57-40FF-80A9-50F09268EC12Q37263905-0528D0A6-2FDE-4B8E-BEDA-4F94B61D66C1Q37979631-1021689F-C2C8-45A6-AD1A-A0F5D283F0B1Q40218474-D1B1169B-B800-422F-85A7-9A7099B46518Q40600918-D669B3D8-740D-4DA3-BEAF-97ACCFCDA5EBQ41934084-52726677-DF2E-453C-905F-5581E8544D92Q48016699-AEC53DAD-E667-44BD-885F-CA3764F5AB7EQ53767337-5B2D6E2A-B4ED-4600-A13D-94081552D1CF
P2860
In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
In vitro activity of pyronarid ...... lciparum and Plasmodium vivax.
@ast
In vitro activity of pyronarid ...... lciparum and Plasmodium vivax.
@en
type
label
In vitro activity of pyronarid ...... lciparum and Plasmodium vivax.
@ast
In vitro activity of pyronarid ...... lciparum and Plasmodium vivax.
@en
prefLabel
In vitro activity of pyronarid ...... lciparum and Plasmodium vivax.
@ast
In vitro activity of pyronarid ...... lciparum and Plasmodium vivax.
@en
P2093
P2860
P50
P921
P356
P1476
In vitro activity of pyronarid ...... lciparum and Plasmodium vivax.
@en
P2093
P2860
P304
P356
10.1128/AAC.00801-10
P407
P577
2010-09-27T00:00:00Z